Skip to main content

Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers.

Publication ,  Journal Article
Jaffe, TA; Wickersham, NW; Sullivan, DC
Published in: AJR Am J Roentgenol
July 2010

OBJECTIVE: The objective of our study was to examine radiologists' opinions and practice patterns concerning tumor measurements in cancer patients. MATERIALS AND METHODS: An electronic mail survey was sent to 565 abdominal imaging radiologists at 55 U.S. National Cancer Institute (NCI)-funded cancer centers. The survey contained questions about departmental demographics, procedures for interpretation of imaging in oncologic patients, and opinions concerning the role of radiologists in using the Response Evaluation Criteria in Solid Tumors (RECIST) system for tumor measurements. RESULTS: Two hundred ninety-six responses (52%) were received. The distribution of the size of the respondents' abdominal imaging groups was as follows: 1-5 (16/295, 5%), 6-10 (112/295, 38%), 11-15 (77/295, 26%), and > 20 (73/295, 25%). Most respondents dictate some but not all tumor measurements in the first clinical scan (236/270, 87%). For follow-up imaging, 95% (255/268) of respondents dictate tumor measurements for selected index lesions. Most respondents believe inclusion of tumor measurements in the first scan is the responsibility of the radiologist (248/262, 95%). Ninety percent of respondents (235/261) believe inclusion of several index lesion measurements is satisfactory to document disease activity. Eighty-two percent (214/260) of respondents were familiar with RECIST. Forty-two percent (110/262) of respondents' departments have a centralized process for approval of industry-sponsored oncologic trials in which imaging is an important component of the protocol end point. CONCLUSION: Most oncologic imaging at NCI-sponsored cancer centers includes tumor measurements on initial and follow-up imaging. Very few radiology departments have a centralized process for approval of clinical trial protocols that require imaging.

Duke Scholars

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

July 2010

Volume

195

Issue

1

Start / End Page

101 / 106

Location

United States

Related Subject Headings

  • United States
  • Tomography, X-Ray Computed
  • Surveys and Questionnaires
  • Practice Patterns, Physicians'
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Neoplasms
  • Humans
  • Clinical Trials as Topic
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jaffe, T. A., Wickersham, N. W., & Sullivan, D. C. (2010). Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers. AJR Am J Roentgenol, 195(1), 101–106. https://doi.org/10.2214/AJR.09.2850
Jaffe, Tracy A., Nicholas W. Wickersham, and Daniel C. Sullivan. “Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers.AJR Am J Roentgenol 195, no. 1 (July 2010): 101–6. https://doi.org/10.2214/AJR.09.2850.
Jaffe TA, Wickersham NW, Sullivan DC. Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers. AJR Am J Roentgenol. 2010 Jul;195(1):101–6.
Jaffe, Tracy A., et al. “Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers.AJR Am J Roentgenol, vol. 195, no. 1, July 2010, pp. 101–06. Pubmed, doi:10.2214/AJR.09.2850.
Jaffe TA, Wickersham NW, Sullivan DC. Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers. AJR Am J Roentgenol. 2010 Jul;195(1):101–106.

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

July 2010

Volume

195

Issue

1

Start / End Page

101 / 106

Location

United States

Related Subject Headings

  • United States
  • Tomography, X-Ray Computed
  • Surveys and Questionnaires
  • Practice Patterns, Physicians'
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Neoplasms
  • Humans
  • Clinical Trials as Topic
  • 3202 Clinical sciences